Long
Aggiornato

SNCA has broken out of a descending channel

257

Catalyst Seneca Biopharma, Inc. (Nasdaq: SNCA) entered into a agreement with a privately held company Leading BioSciences, Inc. (“LBS” for a merger with to form Palisade Bio, Inc.

SNCA has broken out of a descending channel and retested the upper trend line.

The idea is self explanatory targets and stop loss is marked on the chart.

A good risk management is key to success in the financial markets. Risk only a small portion of your portfolio in this risky but potential trade.
Nota
First price target done.
Ordine annullato
Reason for cancel is SNCA ticker will be no more after today becasue of a new ticker PALI as the merger comes into effect.

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.